Production (Stage)
NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 180.53% | 119.26% | -27.46% | 61.01% | 13.20% |
| Total Depreciation and Amortization | -14.08% | 0.71% | -14.35% | -12.18% | -4.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -664.96% | -272.24% | 171.34% | -55.84% | -60.73% |
| Change in Net Operating Assets | -137.30% | -586.82% | 16.98% | 132.11% | 139.98% |
| Cash from Operations | 5.35% | -117.57% | 3.45% | 91.60% | 60.16% |
| Capital Expenditure | -- | -236.36% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00% | 99.20% | -- | -- |
| Cash from Investing | -- | -208.00% | 99.20% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -100.00% | 100.00% | 99.15% | 34.80% |
| Issuance of Common Stock | -92.09% | 25,912.50% | -95.19% | -100.00% | -68.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.36% | 688.28% | 650.18% | -100.20% | -68.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -925.00% | -94.12% | 2,142.11% | -126.91% | -121.70% |